Cargando…

Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

Recently, mesenchymal stem/stromal cells (MSCs) therapy has become an emerging therapeutic modality for the treatment of inflammatory bowel disease (IBD), given their immunoregulatory and pro-survival attributes. MSCs alleviate dysregulated inflammatory responses through the secretion of a myriad of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saadh, Mohamed J., Mikhailova, Maria V., Rasoolzadegan, Soheil, Falaki, Mojgan, Akhavanfar, Roozbeh, Gonzáles, José Luis Arias, Rigi, Amir, Kiasari, Bahman Abedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881387/ https://www.ncbi.nlm.nih.gov/pubmed/36707899 http://dx.doi.org/10.1186/s40001-023-01008-7

Ejemplares similares

Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
por: Gerami, Mohammad Hadi, et al.
Publicado: (2023)

The developmental basis of mesenchymal stem/stromal cells (MSCs)
por: Sheng, Guojun
Publicado: (2015)

Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
por: Yari, Hadi, et al.
Publicado: (2022)

Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
por: Nold, Philipp, et al.
Publicado: (2017)

Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates
por: Siraj, Yesuf, et al.
Publicado: (2023)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
por: Nold, Philipp, et al.
Publicado: (2019)

Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)
por: Pacini, Simone
Publicado: (2014)

Human Bocavirus in Iranian children with acute gastroenteritis
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2013)

MSCs: Scientific Support for Multiple Therapies
por: Pittenger, Mark F., et al.
Publicado: (2015)

Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
por: Zeitouni, Suzanne, et al.
Publicado: (2008)

Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies
por: Kahrizi, Mohammad Saeed, et al.
Publicado: (2023)

NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
por: Hasankhani, Aliakbar, et al.
Publicado: (2023)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

The involving progress of MSCs based therapy in atherosclerosis
por: Lin, Ying, et al.
Publicado: (2020)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Prognostic Factors of Biologic Therapy in Pediatric IBD
por: Buczyńska, Anna, et al.
Publicado: (2022)

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
por: Barnes, Alex, et al.
Publicado: (2022)

The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy
por: Papait, Andrea, et al.
Publicado: (2020)

Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
por: Nazarie (Ignat), Simona-Rebeca, et al.
Publicado: (2021)

Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
por: Gao, Shuang, et al.
Publicado: (2022)

Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration
por: Bouland, Cyril, et al.
Publicado: (2021)

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody
por: Liew, A., et al.
Publicado: (2018)

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
por: Abreu, Maria T, et al.
Publicado: (2022)

Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19
por: Kirkham, Aidan M., et al.
Publicado: (2022)

High abundance of CD271(+) multipotential stromal cells (MSCs) in intramedullary cavities of long bones
por: Cox, George, et al.
Publicado: (2012)

Rat Olfactory Mucosa Mesenchymal Stem/Stromal Cells (OM-MSCs): A Characterization Study
por: Alvites, Rui D., et al.
Publicado: (2020)

Combinations of Hydrogels and Mesenchymal Stromal Cells (MSCs) for Cartilage Tissue Engineering—A Review of the Literature
por: Wagenbrenner, Mike, et al.
Publicado: (2021)

Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
por: Shokravi, Samin, et al.
Publicado: (2022)

Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light
por: Infante, Arantza, et al.
Publicado: (2021)

The promising approach of MSCs therapy for COVID-19 treatment
por: Samanipour, Reza, et al.
Publicado: (2022)

Colony Formation, Migratory, and Differentiation Characteristics of Multipotential Stromal Cells (MSCs) from “Clinically Accessible” Human Periosteum Compared to Donor-Matched Bone Marrow MSCs
por: Owston, Heather E., et al.
Publicado: (2019)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
por: Bucci, Cristina, et al.
Publicado: (2017)

Nanotopography Induced Human Bone Marrow Mesangiogenic Progenitor Cells (MPCs) to Mesenchymal Stromal Cells (MSCs) Transition
por: Antonini, Sara, et al.
Publicado: (2016)

Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
por: Poomani, Merlin Sobia, et al.
Publicado: (2022)

Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme
por: Evans, Subhadra, et al.
Publicado: (2022)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Adherence to lifelines diet score and risk factors of metabolic syndrome among overweight and obese adults: A cross-sectional study
por: Akhavanfar, Roozbeh, et al.
Publicado: (2022)

Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis
por: Szukiewicz, Dariusz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n54fsqeakt1vkin3sri274tdpf